ReviewFrontiers in oncology2026

Functional heterogeneity of TP53 mutants in venetoclax-resistant AML: mechanisms, clinical implications, and therapeutic opportunities.

Maierhaba Maimaitituerhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.